Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment	STARTED	Placebo Comparator: Placebo	14
Treatment	STARTED	Experimental: Etrasimod 2 mg	28
Treatment	COMPLETED	Placebo Comparator: Placebo	4
Treatment	COMPLETED	Experimental: Etrasimod 2 mg	18
Treatment	NOT COMPLETED	Placebo Comparator: Placebo	10
Treatment	NOT COMPLETED	Experimental: Etrasimod 2 mg	10
Follow-up	STARTED	Placebo Comparator: Placebo	14
Follow-up	STARTED	Experimental: Etrasimod 2 mg	28
Follow-up	COMPLETED	Placebo Comparator: Placebo	4
Follow-up	COMPLETED	Experimental: Etrasimod 2 mg	18
Follow-up	NOT COMPLETED	Placebo Comparator: Placebo	10
Follow-up	NOT COMPLETED	Experimental: Etrasimod 2 mg	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04706793/flow